- About Us
- Advertise
- Contact Us
- CureToday.com
- CancerNetwork.com
- OncLive.com
- Do Not Sell My Information
- Privacy
- Terms & Conditions
© 2021 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
Alexander E. Drilon, MD | Authors
Articles
Next Steps for LOXO-292 in RET-Mutant Medullary Thyroid Cancer
March 28, 2019
Video
Alexander E. Drilon, MD, discusses the next steps for LOXO-292 in 2 subsets of patients: those with RET fusion-positive cancers and RET-mutant medullary thyroid cancers.
Prevalence of RET Mutations in Lung and Thyroid Cancers
December 28, 2018
Video
Alexander E. Drilon, MD, discusses the prevalence of RET fusions and mutations in patients with cancer, including lung and thyroid cancers.